This podcast focuses on managing the risks associated with third party relationships, in particular risks related to potential violations of anti-corruption laws — the US Foreign Corrupt Practices Act (FCPA) and the UK Bribery Act, and looks at what might be learned from recent publicly-announced allegations against UK pharmaceutical company, GlaxoSmithKline PLC. Learn best practices for mitigating third-party risk, informed by latest Department of Justice guidance, and explore tools to help implement those practices.